Medigen Biotechnology (3176.TWO) Earnings Analysis
Medigen Biotechnology (3176.TWO) has no confirmed upcoming earnings date. Trailing P/E -17.68.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 3176.TWO next report earnings?
No confirmed upcoming earnings date is currently scheduled for 3176.TWO. This page updates as the calendar is published.
3176.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-12-31 | -0.81809 TWD | n/a | n/a | n/a |
| 2024-09-30 | -0.09472 TWD | n/a | n/a | n/a |
3176.TWO valuation and analyst view
| Trailing P/E | -17.68 |
|---|---|
| Trailing EPS | -1.89798 TWD |
| Price / book | 3.13 |
| Dividend yield | 0.00% |
| Market cap | 4.76B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Medigen Biotechnology (3176.TWO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 3176.TWO. This page updates as the calendar is published.
Did 3176.TWO beat earnings last quarter?
Consensus estimate data was not available for 3176.TWO's 2024-12-31 report.
What is 3176.TWO's current P/E ratio and EPS?
3176.TWO trades at a trailing P/E of -17.68 on trailing EPS of -1.897980718843992 TWD.
What do analysts rate 3176.TWO?
3176.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.